<i>VEGF-A</i> Gene Expression Profiling in Northern Thai Gastric Cancer Patients and Potential for Anti-VEGF Therapy. [PDF]
Sukhamwang A +5 more
europepmc +1 more source
The Evolving Role of Anti-VEGF Therapy in Proliferative Diabetic Retinopathy: Evidence, Challenges, and Future Directions. [PDF]
Li J +5 more
europepmc +1 more source
Efficacy of PD-1/PD-L1 inhibitors combined with anti-VEGF/TKIs and TACE in uHCC: a meta-analysis. [PDF]
Kang X +6 more
europepmc +1 more source
Anti-VEGF versus laser photocoagulation for ROP treatment. [PDF]
Ukey S +4 more
europepmc +1 more source
The Evolving Burden of Age-Related Macular Degeneration in China (1990-2023): Insights from an Aging Society and the Anti-VEGF Era. [PDF]
Chen Z, Liu J, Cheng S, Xu Q.
europepmc +1 more source
Capillary-Large Vessel Segmentation on OCTA for Predicting Anti-VEGF Treatment Outcomes in Diabetic Macular Edema. [PDF]
Huang RB +7 more
europepmc +1 more source
Molecular Determinants of Intravitreal Anti-VEGF Durability: Drug Architecture, Intraocular Pharmacokinetics, Target Biology and Treatment Resistance. [PDF]
Panos GD +8 more
europepmc +1 more source
Effects of Intravitreal Anti-VEGF Therapy on Conjunctival Flora and Antibiotic Resistance in Age-Related Macular Degeneration. [PDF]
Gündüz A, Ekici Gök Z, Evren Ö.
europepmc +1 more source
Peripheral immune dynamics during treatment predict prognosis in HCC receiving TACE plus ICIs and anti-VEGF/TKIs. [PDF]
Qin L +6 more
europepmc +1 more source
Systemic and ocular complications related to intravitreal administration of anti-VEGF agents. [PDF]
Koksaldi S +3 more
europepmc +1 more source

